Post by Lonza

At this year’s Antibody Industrial Symposium, Lonza is hosting the panel: “From science to strategy: Making biotech ventures investment‑ready.” The discussion will explore how early‑stage programs can be shaped into investable opportunities, covering investor expectations, outsourcing decisions, and integrated development strategies that reduce risk from target validation through IND. Our experts Yvette Stallwood and Laurence Bonnafoux will guide the conversation, bringing a practical perspective on how to build programs that are both scientifically robust and strategically aligned. 📅 Tuesday, 30 June 2026 | 13:00 – 14:00 📍 Antibody Industrial Symposium | Montpellier, France 🏛️ Corum Congress Centre | Barthez Room #AIS2026 #AntibodyIndustrialSymposium #Lonza #Biotech #CDMO